Order Entry
Hungary
Orders LinkContactUsLinkComponent
Bendamustine Related Compound, Reference Standard

Bendamustine Related Compound, Reference Standard

 :   USP
Bendamustine Related Compound, Reference Standard
 :  USP
 
Bendamustine Related Compound, Reference Standard

 

 

USP Reference Standards are specified for use in conducting official USP–NF tests and assays. To confirm accuracy and reproducibility, USP Reference Standards are rigorously tested and evaluated by multiple independent laboratories including USP, commercial, regulatory, and academic labs. USP also provide publicly available, official documentary standards for pharmaceutical ingredients in the USP–NF that link directly with our primary reference standards.

Certifications: US Pharmacopea Reference Standard

 

 

 

  • Catalog No:
  • 1065232.
  • 1065301.
  • 1065243.
  • 1065254.
  • 1065265.
  • 1065276.
  • 1065298.
  • 1065312.
  • Description:
  • Bendamustine Related Compound A
  • Bendamustine Related Compound H
  • Bendamustine Related Compound B
  • Bendamustine Related Compound C
  • Bendamustine Related Compound D
  • Bendamustine Related Compound E
  • Bendamustine Related Compound G
  • Bendamustine Related Compound I
  • Synonym(s):
  • 4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride
  • 4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H-benzimidazol-2-yl]butanoic acid
  • 4-(1-Methyl-5-morpholino-1H-benzimidazol-2-yl)butanoic acid hydrochloride
  • Ethyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate
  • 4-{5-[(2-Chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoic acid hydrochloride
  • 4-{5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid
  • 4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid hydrochloride
  • Ethyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoate
  • CAS No.:
  • 109882-29-3
  • 1228551-91-4
  • 3543-74-6
  • 1797881-48-1
  • 109882-27-1
  • 87475-54-5
  • Formula:
  • C₃₂H₄₁Cl₃N₆O₄
  • C₁₆H₂₁N₃O₃,xHCl
  • C₁₄H₁₉Cl₂N₃O₂
  • C₁₆H₂₂ClN₃O₃
  • C₁₈H₂₅Cl₂N₃O₂

 

Product Family Options

 

  • Description
    Standards
    Pack type
    Pk
     
     
  • Bendamustine Related Compound A
    USP reference standard
    Vial
    25 mg
       
       
    1 * 25 mg
    1 * 25 mg - 464 550 Ft
    464 550 Ft
    1 * 25 mg
       464 550 Ft

     
     
    Specifications
    Cat. No.
    1065232.
    Description
    Bendamustine Related Compound A
    Synonym(s)
    4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride
    CAS No.
    109882-29-3
    Formula
  • Bendamustine Related Compound H
    USP reference standard
    Vial
    25 mg
       
       
    1 * 25 mg
    1 * 25 mg - 410 190 Ft
    410 190 Ft
    1 * 25 mg
       410 190 Ft

     
     
    Specifications
    Cat. No.
    1065301.
    Description
    Bendamustine Related Compound H
    Synonym(s)
    4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H-benzimidazol-2-yl]butanoic acid
    CAS No.
    1228551-91-4
    Formula
    C₃₂H₄₁Cl₃N₆O₄
  • Bendamustine Related Compound B
    USP reference standard
    Vial
    20 mg
       
       
    1 * 20 mg
    1 * 20 mg - 502 000 Ft
    502 000 Ft
    1 * 20 mg
       502 000 Ft

     
     
    Specifications
    Cat. No.
    1065243.
    Description
    Bendamustine Related Compound B
    Synonym(s)
    4-(1-Methyl-5-morpholino-1H-benzimidazol-2-yl)butanoic acid hydrochloride
    CAS No.
    Formula
    C₁₆H₂₁N₃O₃,xHCl
  • Bendamustine Related Compound C
    USP reference standard
    Vial
    20 mg
       
       
    1 * 20 mg
    1 * 20 mg - 1 229 000 Ft
    1 229 000 Ft
    1 * 20 mg
       1 229 000 Ft

     
     
    Specifications
    Cat. No.
    1065254.
    Description
    Bendamustine Related Compound C
    Synonym(s)
    Ethyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate
    CAS No.
    3543-74-6
    Formula
  • Bendamustine Related Compound D
    USP reference standard
    Vial
    20 mg
       
       
    1 * 20 mg
    1 * 20 mg - 436 000 Ft
    436 000 Ft
    1 * 20 mg
       436 000 Ft

     
     
    Specifications
    Cat. No.
    1065265.
    Description
    Bendamustine Related Compound D
    Synonym(s)
    4-{5-[(2-Chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoic acid hydrochloride
    CAS No.
    1797881-48-1
    Formula
    C₁₄H₁₉Cl₂N₃O₂
  • Bendamustine Related Compound E
    USP reference standard
    Vial
    20 mg
       
       
    1 * 20 mg
    1 * 20 mg - 465 000 Ft
    465 000 Ft
    1 * 20 mg
       465 000 Ft

     
     
    Specifications
    Cat. No.
    1065276.
    Description
    Bendamustine Related Compound E
    Synonym(s)
    4-{5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid
    CAS No.
    109882-27-1
    Formula
    C₁₆H₂₂ClN₃O₃
  • Bendamustine Related Compound G
    USP reference standard
    Vial
    20 mg
       
       
    1 * 20 mg
    1 * 20 mg - 465 000 Ft
    465 000 Ft
    1 * 20 mg
       465 000 Ft

     
     
    Specifications
    Cat. No.
    1065298.
    Description
    Bendamustine Related Compound G
    Synonym(s)
    4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid hydrochloride
    CAS No.
    Formula
  • Bendamustine Related Compound I
    USP reference standard
    Vial
    25 mg
       
       
    1 * 25 mg
    1 * 25 mg - 403 000 Ft
    403 000 Ft
    1 * 25 mg
       403 000 Ft

     
     
    Specifications
    Cat. No.
    1065312.
    Description
    Bendamustine Related Compound I
    Synonym(s)
    Ethyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoate
    CAS No.
    87475-54-5
    Formula
    C₁₈H₂₅Cl₂N₃O₂